AnaptysBio Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, AnaptysBio stock has a consensus rating of "Strong Buy" and an average price target of $87.09. The average 1-year stock price forecast is 51.43% higher than the current stock price, while the lowest is $70 (+21.72%) and the highest is $140 (+143.44%).

Price Target: $87.09 (+51.43%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$70	$87.09	$81	$140
Change	+21.72%	+51.43%	+40.85%	+143.44%

Analyst Ratings

The average analyst rating for AnaptysBio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	9	9	9	7	8	8
Buy	3	3	3	3	3	3
Hold	1	1	1	1	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	13	13	13	11	11	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Joseph Pantginis H.C. Wainwright	H.C. Wainwright	Buy Initiates $95	Buy	Initiates	$95	+65.19%	Jun 10, 2026
David Risinger Leerink Partners	Leerink Partners	Buy Reiterates n/a	Buy	Reiterates	n/a	n/a	May 27, 2026
Anupam Rama J.P. Morgan	J.P. Morgan	Buy Maintains $69 → $70	Buy	Maintains	$69 → $70	+21.72%	May 23, 2026
Michael Yee UBS	UBS	Buy Maintains $60 → $76	Buy	Maintains	$60 → $76	+32.15%	May 13, 2026
Yasmeen Rahimi Piper Sandler	Piper Sandler	Buy Maintains $93	Buy	Maintains	$93	+61.71%	May 13, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

109.99M

from 234.60M

-53.12%

from 234.60M

Revenue Next Year

153.62M

from 109.99M

39.67%

from 109.99M

EPS This Year

-0.23

from -0.46

EPS Next Year

5.24

from -0.23

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	63.18M	10.29M	17.16M	91.28M	234.60M	109.99M
Revenue Growth	-15.77%	-83.72%	66.78%	432.03%	157.02%	-53.12%
Gross Profit	-35.32M	-78.51M	-115.13M	-72.56M	98.63M	109.99M
Gross Margin	-55.91%	-763.21%	-671.01%	-79.49%	42.04%	100.00%
Operating Income	-56.81M	-115.15M	-157.07M	-114.95M	47.90M	16.39M
Net Income	-57.80M	-128.72M	-163.62M	-145.23M	-13.23M	-7.47M
EPS	-	-	-	-	-0.46	-0.23
Free Cash Flow	-28.10M	-46.19M	-73.42M	-89.79M	19.34M	20.00M
No. Analysts	-	-	-	-	-	6

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	191.1M
Avg	110.0M
Low	25.6M

Revenue Growth

Revenue Growth	2026	2027	2028
High	-18.5%
Avg	-53.1%
Low	-89.1%

EPS Forecast

EPS	2026	2027	2028
High	2.49
Avg	-0.23
Low	-2.63

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-